<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=HLA-DO</id>
	<title>HLA-DO - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=HLA-DO"/>
	<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=HLA-DO&amp;action=history"/>
	<updated>2026-04-22T04:55:50Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.com/index.php?title=HLA-DO&amp;diff=5297455&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=HLA-DO&amp;diff=5297455&amp;oldid=prev"/>
		<updated>2024-02-25T20:55:25Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;HLA-DO&amp;#039;&amp;#039;&amp;#039; is a protein that in humans is encoded by the HLA-DOA and HLA-DOB genes. HLA-DO is an intracellular heterodimer that plays a critical role in the presentation of antigens to the immune system. It is part of the [[Major Histocompatibility Complex]] (MHC) class II molecules, which are expressed in antigen-presenting cells (APCs).&lt;br /&gt;
&lt;br /&gt;
== Structure ==&lt;br /&gt;
HLA-DO is composed of two non-covalently associated subunits, alpha (DOA) and beta (DOB). The alpha chain is encoded by the HLA-DOA gene, while the beta chain is encoded by the HLA-DOB gene. Both genes are located within the MHC class II region on chromosome 6.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
HLA-DO functions as a negative regulator of the immune response. It inhibits the peptide loading of [[MHC class II]] molecules by blocking the binding of the invariant chain (Ii) and the HLA-DM molecule. This results in a reduced ability of the immune system to respond to foreign antigens.&lt;br /&gt;
&lt;br /&gt;
== Clinical significance ==&lt;br /&gt;
Alterations in the expression of HLA-DO have been associated with various autoimmune diseases, including [[rheumatoid arthritis]] and [[multiple sclerosis]]. Further research is needed to fully understand the role of HLA-DO in these conditions.&lt;br /&gt;
&lt;br /&gt;
== See also ==&lt;br /&gt;
* [[Major Histocompatibility Complex]]&lt;br /&gt;
* [[MHC class II]]&lt;br /&gt;
* [[Antigen-presenting cell]]&lt;br /&gt;
* [[Autoimmune disease]]&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Human proteins]]&lt;br /&gt;
[[Category:Immune system]]&lt;br /&gt;
[[Category:Genes on human chromosome 6]]&lt;br /&gt;
{{stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>